• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏中阳离子的体内化学特性

Characterization of in vivo chemistry of cations in the heart.

作者信息

Mousa S A, Williams S J, Sands H

出版信息

J Nucl Med. 1987 Aug;28(8):1351-7.

PMID:3302134
Abstract

A variety of laboratory procedures can be used to define the chemistry and pharmacokinetics of myocardial cationic imaging agents. These methods are utilized to define the in vivo chemistry of cationic heart agents, in order to understand the kinetics and mechanisms of: tissue and cellular transport, subcellular distribution, and intracellular localization. Transport across cell membranes can be active, passive or facilitated. Studies performed in erythrocytes, heart cells, slices and isolated perfused hearts using methods for separation of metabolites have shown a high degree of myocardial specificity for [99mTc]hexakis alkyl isonitrile by an uptake mechanism different from 201Tl. These studies demonstrate the importance of in vivo chemistry and pharmacokinetics in the development of new radiopharmaceuticals.

摘要

多种实验室程序可用于确定心肌阳离子显像剂的化学性质和药代动力学。这些方法用于定义阳离子心脏显像剂的体内化学性质,以便了解组织和细胞转运、亚细胞分布及细胞内定位的动力学和机制。跨细胞膜的转运可以是主动的、被动的或易化的。利用代谢物分离方法在红细胞、心脏细胞、切片和离体灌注心脏中进行的研究表明,[99mTc]六烷基异腈对心肌具有高度特异性,其摄取机制不同于201Tl。这些研究证明了体内化学性质和药代动力学在新型放射性药物开发中的重要性。

相似文献

1
Characterization of in vivo chemistry of cations in the heart.心脏中阳离子的体内化学特性
J Nucl Med. 1987 Aug;28(8):1351-7.
2
Uptake of hexakis(t-butylisonitrile) technetium (I) and hexakis(isopropylisonitrile) technetium (I) by neonatal rat myocytes and human erythrocytes.
J Nucl Med. 1986 Mar;27(3):404-8.
3
99mTc hexakis-t-butyl isonitrile (TBI): an agent for the diagnosis of coronary artery diseases.
Int J Clin Pharmacol Ther Toxicol. 1989 Feb;27(2):66-75.
4
Human pharmacokinetics and radiopharmacological studies of the myocardial perfusion agent: technetium (2-carbomethoxy-2-isocyano-propane)6+.心肌灌注剂锝(2-甲氧羰基-2-异氰基丙烷)6+的人体药代动力学和放射性药物学研究。
J Nucl Med. 1992 Nov;33(11):1949-57.
5
Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells.六(2-甲氧基异丁基异腈)锝-99m与氯化铊-201:在培养心肌细胞中的摄取与释放
J Nucl Med. 1988 Jan;29(1):48-54.
6
Comparison of hypoxia and ouabain effects on the myocardial uptake kinetics of technetium-99m hexakis 2-methoxyisobutyl isonitrile and thallium-201.
J Nucl Med. 1989 Sep;30(9):1500-6.
7
Hexakis(carbomethoxyisopropylisonitrile) technetium(I), a new myocardial perfusion imaging agent: binding characteristics in cultured chick heart cells.六(甲氧羰基异丙基异腈)锝(I),一种新型心肌灌注显像剂:在培养鸡心脏细胞中的结合特性
J Nucl Med. 1988 Jan;29(1):55-61.
8
Cationic complexes of technetium for myocardial imaging.
J Nucl Med. 1989 Aug;30(8):1415-9.
9
Comparison of technetium-99m MIBI and thallium-201 chloride myocardial scintigraphy in infants.
J Nucl Med. 1989 Jul;30(7):1176-81.
10
Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.99m锝-甲氧基异丁基异腈在离体灌注大鼠心脏中的亚细胞分布及分析
J Nucl Med. 1992 Aug;33(8):1516-22.

引用本文的文献

1
Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria.
J Nucl Cardiol. 1995 Jul-Aug;2(4):327-33. doi: 10.1016/s1071-3581(05)80077-7.
2
Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization.锝-替曲膦摄取机制。I:摄取至成年大鼠离体心室肌细胞及亚细胞定位
J Nucl Cardiol. 1995 Jul-Aug;2(4):317-26. doi: 10.1016/s1071-3581(05)80076-5.
3
The birth of a new radiopharmaceutical. Industrial perspective: from IND to NDA.一种新型放射性药物的诞生。行业视角:从研究性新药申请到新药申请。
J Nucl Cardiol. 1995 Jan-Feb;2(1):66-70. doi: 10.1016/s1071-3581(05)80010-8.
4
Effectiveness of Tc-99m MIBI scintigraphy in diagnosing lung cancer.锝-99m甲氧基异丁基异腈闪烁显像在诊断肺癌中的有效性。
Surg Today. 1997;27(7):623-6. doi: 10.1007/BF02388218.
5
A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: possible implications for myocardial viability detection in infarcted patients.静息态心肌灌注显像剂锝-99m甲氧基异丁基异腈(sestamibi)与静息-再分布铊单光子发射计算机断层扫描(SPECT)的比较:对梗死患者心肌存活检测的可能意义。
Eur J Nucl Med. 1993 Jan;20(1):26-31. doi: 10.1007/BF02261242.
6
Radionuclide targeting and dosimetry at the microscopic level: the role of microautoradiography.微观层面的放射性核素靶向与剂量测定:微放射自显影的作用。
Eur J Nucl Med. 1994 Dec;21(12):1347-65. doi: 10.1007/BF02426701.
7
Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention.线粒体活力和代谢对锝-99m-甲氧基异丁基异腈心肌摄取的影响。
Eur J Nucl Med. 1993 Jan;20(1):20-5. doi: 10.1007/BF02261241.
8
The significance of a dipyridamole induced 99mTc-MIBI perfusion abnormality on single photon emission tomography: a quantitative validation with labelled water and positron emission tomography.双嘧达莫诱导的99mTc-MIBI灌注异常在单光子发射断层扫描中的意义:用标记水和正电子发射断层扫描进行定量验证
Eur J Nucl Med. 1992;19(12):1044-9. doi: 10.1007/BF00180866.